Bellerophon Therapeutics, Inc.: cash_and_equivalents

Value{"amount": 30605000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Period (as of 2014-09-30)
Statuscurrent
EntityBellerophon Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001104659-15-078036 · Open the official SEC filing →
Retrieved: 2026-08-19T16:22:41.642204+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001600132/cash-and-equivalents/2014-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/1bccafc4-095d-4775-80eb-37474cd061e0

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies